Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Chloé Rauzier"'
Autor:
Chloé Rauzier, Dominic J. Chartrand, Natalie Alméras, Isabelle Lemieux, Eric Larose, Patrick Mathieu, Philippe Pibarot, Benoît Lamarche, Caroline Rhéaume, Paul Poirier, Jean-Pierre Després, Frédéric Picard
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
Lay summaryObesity is frequently accompanied by a fatty liver. However, some individuals with high abdominal fat levels nevertheless have low levels of liver fat. Reasons for such discordant phenotypes are unclear. In this paper, we report that among
Externí odkaz:
https://doaj.org/article/3993bba47da94f5a883023aca6c54bd9
Publikováno v:
Journal of Lipid Research, Vol 63, Iss 10, Pp 100269- (2022)
Low circulating concentrations of insulin-like growth factor binding protein-2 (IGFBP-2) have been associated with dyslipidemia, notably with high triglyceride (TG) levels. However, the determinants by which IGFBP-2 influences lipoprotein metabolism,
Externí odkaz:
https://doaj.org/article/804beca5debc4829ac7466d82ff842ad
Autor:
Marie-France Demers, Camille Cadrin, Frédéric Picard, Marc-André Roy, Marc-André Nolin, Roch-Hugo Bouchard, Jean-Pierre Després, Chloé Rauzier, Natalie Alméras
Publikováno v:
The World Journal of Biological Psychiatry. 22:175-182
Second generation antipsychotics (SGAs) induce weight gain and dyslipidemia, albeit with important intervariability. Insulin-like growth factor binding protein (IGFBP)-2 is proposed as a circulating biomarker negatively associated with waist circumfe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee7f001a7db31fc95d85238302466878
https://doi.org/10.1080/15622975.2020.1770858
https://doi.org/10.1080/15622975.2020.1770858
Autor:
Natalie Alméras, Chloé Rauzier, Roch-Hugo Bouchard, Jean-Pierre Després, Frédéric Picard, Marc-André Roy, Marie-France Demers, Marc-André Nolin
BACKGROUND: Despite their important clinical value, second generation antipsychotics (SGAs) are known to induce weight gain, insulin resistance, and dyslipidemia. However, the extent of these metabolic alterations differs among patients, and there is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55ae13651b8a9525f566374256eb0ab4
https://europepmc.org/articles/PMC6455041/
https://europepmc.org/articles/PMC6455041/
